Neuchâtel, Switzerland, June 1, 2010 - Elsevier Properties SA announces the winners of the Reaxys PhD Prize, a competition for candidates currently studying for a PhD or having completed a PhD within the last 12 months. The Prize recognizes research excellence in the fields of organic, organometallic and inorganic chemistry.
Over 300 submissions were received after the prize was launched in January 2010. Submissions consisted of a representative peer-reviewed piece of published research, a PhD Supervisor letter of recommendation and a CV. All entries were reviewed by a review board of over 50 leading international chemists and judged for originality, innovation, importance to the field, applicability, rigor of approach and publication quality.
The winners of the Reaxys PhD Prize are:
- Thomas Maimone (Massachusetts Institute of Technology, USA)
- Hiroyuki Miyamura (University of Tokyo, Japan)
- Robert Phipps (University of Cambridge, UK)
The runners-up of the Reaxys PhD Prize are: Victoria Blair (University of Strathclyde), Justin Chalker (University of Oxford), Justin Christy (Stanford University), Nicholas Deprez (University of Michigan), Guangbin Dong (California Institute of Technology), Alessandro D'Urso (University of Catania), Brett Fors (Massachusetts Institute of Technology), Xiao Fu (National University of Singapore), Takeru Furuya (Harvard University), Stefan Graber (University of Basel), Yuan Han (National University of Singapore), Takanori Iwasaki (Osaka University), Bala Krishna Juluri (Pennsylvania State University), Michael Katz (Simon Fraser University), Florian Kessler (University Konstanz), Ponminor Senthil Kumar (Indian Institute of Technology), Ravi Kumar (Indian Association for the Cultivation of Science), Jin LiQun (Wuhan University), Connor Martin (University of California, Irvine), Teresa Martinez Del Campo (Universidad Complutense de Madrid), Megan Matthews (Pennsylvania State University), Paul McGonigal (University of Edinburgh), David Michaelis (University of Wisconsin-Madison), Evan Miller (University of California, San Diego), Thomas Moss (University of Manchester), Devon Mundal (Northwestern University), Julia Neumann (Westfälische Wilhelms-Universität Münster), Tobias Seiser (ETH Zurich), Rohit Kumar Sharma (National Institute of Pharmaceutical Education & Research), Lauren Sirois (Stanford University), Christof Sparr (ETH, Zurich), Jason Spruell (Northwestern University), Yuto Sumida (Kyoto University), Kosuke Suzuki (University of Tokyo), Giulia Tagliabue (University of Insubria), Jason Thomas (University of British Columbia), Hirofumi Ueda (Tohoku University), Akira Ueda (Osaka University), Oleg Vechorkin (Ecole Polytechnique Fédérale de Lausanne), Dieter Weber (University of North Carolina at Chapel Hill), Peter Wich (University of California, Berkeley), and Akira Yada (Kyoto University)
The final selection was made by the Regional Coordinators who are all members of the Reaxys Advisory Board:
- Dr. P. Kocis - former Global Head Exploratory Chemistry, AstraZeneca
- Professor H. Kunz - University of Mainz, Germany
- Professor H. N. C. Wong - Chinese University of Hong Kong, Hong Kong, China
The winners and runners-up have been invited to attend the Reaxys PhD Prize Symposium at the 3rd EuCheMS Chemistry Congress on Monday, August 30, 2010. The winners are invited to give a short oral presentation of their research, and the finalists will participate in a special poster session and reception.
The symposium will also include presentations from Dr. Graeme Robertson, VP Portfolio Management, Siena Biotech and Prof. Erick Carreira, Laboratory of Organic Chemistry, ETH, Zurich, Switzerland.
David Evans PhD, Scientific Affairs Director at Elsevier Properties SA said today, "The quality of the submissions we received was excellent. The review board had some very difficult decisions to make when agreeing on the winners." He continued, "The Reaxys PhD Prize celebrates the creativity, quality of research and scientific rigor of some of the finest young chemists in the world. These qualities lie at the heart of Reaxys which strives through a thorough understanding of chemists' needs, to enhance their research workflows and support their innovation."
For further information please see prize.reaxys.com, and www.info.reaxys.com
About Elsevier Properties SA
Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, Beilstein and Reaxys databases. Trademarks including Reaxys®, PharmaPendium™ and The Lancet® are owned and protected by Elsevier Properties SA and used under license. For additional information see www.reedelsevier.com.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including the Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai's Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).